The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 524 KB) and Technical Notes (PDF, 756 KB) pages.



Download and Print: Download Printer-friendly PDF Download data


Table 5.16

Cancer of the Cervix Uteri (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases, 2009-2013
Females by Race
Histologya All Races White Black Asian/
Pacific Islander
American Indian
/Alaska Nativeb
Hispanicc
Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent
Carcinoma 16,162 98.1% 12,048 98.3% 2,262 97.2% 1,480 98.1% 128 99.2% 3,566 98.2%
Epidermoid carcinomad (8050-8131) 10,803 65.6% 7,832 63.9% 1,754 75.4% 972 64.5% 78 60.5% 2,437 67.1%
Squamous cell carcinoma (8070) 7,524 45.7% 5,431 44.3% 1,254 53.9% 662 43.9% 58 45.0% 1,558 42.9%
Squamous cell, keratinizing (8071) 1,140 6.9% 801 6.5% 201 8.6% 113 7.5% - - 306 8.4%
Squamous cell, non-keratinizing (8072) 1,460 8.9% 1,090 8.9% 199 8.6% 143 9.5% - - 409 11.3%
Squamous cell, Microinvasive (8076) 424 2.6% 322 2.6% 58 2.5% 31 2.1% - - 103 2.8%
Other (8050-8069, 8073-8075,8077-8131) 255 1.5% 188 1.5% 42 1.8% 23 1.5% - - 61 1.7%
Adenocarcinomae 4,655 28.2% 3,716 30.3% 391 16.8% 439 29.1% 43 33.3% 981 27.0%
Adenocarcinoma, NOS (8140) Adenosquamous (8560,8570) 2,488 15.1% 2,001 16.3% 207 8.9% 222 14.7% 20 15.5% 544 15.0%
553 3.4% 413 3.4% 63 2.7% 70 4.6% - - 117 3.2%
Other adenocarcinomasf 1,614 9.8% 1,302 10.6% 121 5.2% 147 9.7% 18 14.0% 320 8.8%
Other specific carcinomasg 265 1.6% 192 1.6% 41 1.8% 29 1.9% - - 43 1.2%
Unspecified, Carcinoma, NOS (8010-8011,8020-8022) 439 2.7% 308 2.5% 76 3.3% 40 2.7% - - 105 2.9%
Sarcomah 59 0.4% 38 0.3% - - - - - - - -
Other specific types (8720-8790,8930-8936, 8950-9030,9060-9110, 9260-9365,9380-9539) 163 1.0% 105 0.9% 33 1.4% 19 1.3% - - 32 0.9%
Unspecified (8000-8005) 96 0.6% 69 0.6% 17 0.7% - - - - 21 0.6%
Total 16,480 100.0% 12,260 100.0% 2,327 100.0% 1,508 100.0% 129 100.0% 3,633 100.0%

Footnotes:

Source: SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG). Percents may not sum to 100 due to rounding.

a Excludes Kaposi Sarcoma, mesothelioma, lymphomas, leukemias, myelomas, lymphoreticular, and immunoproliferative diseases.

b Estimates for American Indian/Alaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties.

c Hispanic is not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives. Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry.

d Epidermoid carcinoma includes squamous, basal, and transitional cell carcinomas.

e Adenocarcinoma includes histologies 8140-8147,8160-8162,8180-8221,8250-8507,8514,8520-8551,8560,8570-8574,8576,8940-8941.

f Other adenocarcinomas include histologies 8141-8147,8160-8162,8180-8221,8250-8507,8514,8520-8551,8571-8574,8576,8940-8941.

g Other specific carcinomas include histologies 8012-8015,8030-8046,8150-8155,8170-8175,8230-8249,8508,8510-8513,8561-8562, 8575,8580-8671.

h Sarcoma includes histologies 8680-8713,8800-8921,9040-9044,9120-9136,9150-9252,9370-9373,9540-9582.

- Statistic not shown due to fewer than 16 cases during the time period.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.